Junyi Wu

100 Haining Road
Hongkou, 200080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Ursolic acid suppresses triple-negative breast cancer progression through mediating FABP4/PPARG pathway.

Ursolic acid suppresses triple-negative breast cancer progression through mediating FABP4/PPARG pathway.

Journal: European journal of medical research

Published: April 09, 2025

Effect of hypoxia‑HIF‑1α‑periostin axis in thyroid cancer.

Effect of hypoxia‑HIF‑1α‑periostin axis in thyroid cancer.

Journal: Oncology reports

Published: August 10, 2023

Correction to: OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.

Correction to: OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.

Journal: Oncogene

Published: May 31, 2023

Clinical value of CTLA4 combined with clinicopathological factors in evaluating the prognosis of breast cancer.

Clinical value of CTLA4 combined with clinicopathological factors in evaluating the prognosis of breast cancer.

Journal: Gland surgery

Published: November 23, 2020

YEATS4 is associated with poor prognosis and promotes epithelial-to-mesenchymal transition and metastasis by regulating ZEB1 expression in breast cancer.

YEATS4 is associated with poor prognosis and promotes epithelial-to-mesenchymal transition and metastasis by regulating ZEB1 expression in breast cancer.

Journal: American journal of cancer research

Published: June 19, 2020

OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.

OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.

Journal: Oncogene

Published: February 22, 2020

High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer.

High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer.

Journal: Breast cancer research and treatment

Published: December 13, 2019

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy.

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy.

Journal: OncoTargets and therapy

Published: October 19, 2017

Prognostic values of Notch receptors in breast cancer.

Prognostic values of Notch receptors in breast cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: August 08, 2015

The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.

The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 24, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026